{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:52:06Z","timestamp":1762005126611},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Children's Memorial Health Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Zellweger spectrum disorders (ZSD) constitute a group of rare autosomal recessive disorders characterized by a defect in peroxisome biogenesis due to mutations in one of 13 <jats:italic>PEX<\/jats:italic> genes. The broad clinical heterogeneity especially in late-onset presenting patients and a mild phenotype complicates and delays the diagnostic process. Here, we report a case of mild ZSD, due to novel <jats:italic>PEX1<\/jats:italic> variants. The patient presented with an early hearing loss, bilateral cataracts, and leukodystrophy on magnetic resonance (MR) images. Normal results of serum very-long-chain fatty acids (VLCFA) and phytanic acid were found. Molecular diagnostics were performed to uncover the etiology of the clinical phenotype. Using whole exome sequencing, there have been found two variants in the <jats:italic>PEX1<\/jats:italic> gene\u2014c.3450T&gt;A (p.Cys1150*) and c.1769T&gt;C (p.Leu590Pro)<jats:italic>.<\/jats:italic> VLCFA measurement in skin fibroblasts and C26:0-lysoPC in dried blood spot therefore was performed. Both results were in line with the diagnosis of ZSD. To conclude, normal results of routine serum VLCFA and branched-chain fatty acid measurement do not exclude mild forms of ZSD. The investigation of C26:0-lysoPC should be included in the diagnostic work-up in patients with cataract, hearing loss, and leukodystrophy on MR images suspected to suffer from ZSD.<\/jats:p>","DOI":"10.1007\/s13353-019-00523-w","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T16:24:33Z","timestamp":1571415873000},"page":"87-91","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants"],"prefix":"10.1007","volume":"61","author":[{"given":"Patryk","family":"Lipi\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Stawi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Rydzanicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Wypch\u0142o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"P\u0142oski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Joanna","family":"Stradomska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Jurkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha","family":"Ferdinandusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J. A.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"523_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10545-015-9880-2","volume":"39","author":"K Berendse","year":"2016","unstructured":"Berendse K, Engelen M, Ferdinandusse S et al (2016) Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J Inherit Metab Dis 39:93\u2013106","journal-title":"J Inherit Metab Dis"},{"key":"523_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jmg.2009.074302","volume":"47","author":"MS Ebberink","year":"2010","unstructured":"Ebberink MS, Csanyi B, Chong WK et al (2010) Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. J Med Genet 47:608\u2013615","journal-title":"J Med Genet"},{"key":"523_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/jmedgenet-2012-100778","volume":"49","author":"MS Ebberink","year":"2012","unstructured":"Ebberink MS, Koster J, Visser G et al (2012) A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11\u03b2 gene. J Med Genet 49:307\u2013313","journal-title":"J Med Genet"},{"key":"523_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-015-0368-9","volume":"10","author":"FCC Klouwer","year":"2015","unstructured":"Klouwer FCC, Berendse K, Ferdinandusse S et al (2015) Zellweger spectrum disorders: clinical overview and management approach inherited metabolic diseases. Orphanet J Rare Dis 10:151","journal-title":"Orphanet J Rare Dis"},{"key":"523_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0036-1582140","volume":"47","author":"FCC Klouwer","year":"2016","unstructured":"Klouwer FCC, Huffnagel IC, Ferdinandusse S et al (2016) Clinical and biochemical pitfalls in the diagnosis of Peroxisomal disorders. Neuropediatrics 47:205\u2013220","journal-title":"Neuropediatrics"},{"key":"523_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10545-017-0064-0","volume":"40","author":"FCC Klouwer","year":"2017","unstructured":"Klouwer FCC, Ferdinandusse S, van Lenthe H et al (2017) Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders. J Inherit Metab Dis 40:875\u2013881","journal-title":"J Inherit Metab Dis"},{"key":"523_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/cge.13130","volume":"93","author":"FCC Klouwer","year":"2018","unstructured":"Klouwer FCC, Meester-Delver A, Vaz FM et al (2018) Development and validation of a severity scoring system for Zellweger spectrum disorders. Clin Genet 93:613\u2013621","journal-title":"Clin Genet"},{"key":"523_CR8","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/CIRCRESAHA.114.302662","volume":"114","author":"R Ploski","year":"2014","unstructured":"Ploski R, Pollak A, Muller S et al (2014) Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy? Circ Res 114:e2\u2013e5","journal-title":"Circ Res"},{"key":"523_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1086\/339766","volume":"70","author":"A Raas-Rothschild","year":"2002","unstructured":"Raas-Rothschild A, Wanders RJ, Mooijer PA et al (2002) A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. Am J Hum Genet 70:1062\u20131068","journal-title":"Am J Hum Genet"},{"key":"523_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13353-017-0414-5","volume":"58","author":"M Rydzanicz","year":"2017","unstructured":"Rydzanicz M, Stradomska TJ, Jurkiewicz E et al (2017 Nov) Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity. J Appl Genet 58:475\u2013480","journal-title":"J Appl Genet"},{"key":"523_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-6-8","volume":"6","author":"C Sevin","year":"2011","unstructured":"Sevin C, Ferdinandusse S, Waterham HR et al (2011) Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. Orphanet J Rare Dis 6:8","journal-title":"Orphanet J Rare Dis"},{"key":"523_CR12","first-page":"197","volume":"71","author":"TJ Stradomska","year":"1996","unstructured":"Stradomska TJ, Tylki-Szyma\u0144ska A (1996) Examination of very long chain fatty acids in diagnosis of X-linked adrenoleukodystrophy. Pediatr Pol 71:197\u2013201","journal-title":"Pediatr Pol"},{"key":"523_CR13","first-page":"306","volume":"47","author":"TJ Stradomska","year":"2009","unstructured":"Stradomska TJ, Tylki-Szyma\u0144ska A (2009) Serum very-long-chain fatty acids levels determined by gas chromatography in the diagnosis of peroxisomal disorders in Poland. Folia Neuropathol 47:306\u2013313","journal-title":"Folia Neuropathol"},{"key":"523_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0387-7604(03)00033-0","volume":"25","author":"Y Takemoto","year":"2003","unstructured":"Takemoto Y, Suzuki Y, Horibe R et al (2003) Gas chromatography\/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain and Development 25:481\u2013487","journal-title":"Brain and Development"},{"key":"523_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.pediatrneurol.2014.03.020","volume":"51","author":"C Tran","year":"2014","unstructured":"Tran C, Hewson S, Steinberg SJ, Mercimek-Mahmutoglu S (2014) Late-onset Zellweger spectrum disorder caused by PEX6 mutations mimicking X-linked adrenoleukodystrophy. Pediatr Neurol 51:262\u2013265","journal-title":"Pediatr Neurol"},{"key":"523_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ymgmr.2016.10.006","volume":"9","author":"MJ Ventura","year":"2016","unstructured":"Ventura MJ, Wheaton D, Xu M et al (2016) Diagnosis of a mild peroxisomal phenotype with next-generation sequencing. Mol Genet Metab Rep 9:75\u201378","journal-title":"Mol Genet Metab Rep"},{"key":"523_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-4939-6937-1_30","volume":"1595","author":"RJ Wanders","year":"2017","unstructured":"Wanders RJ, Klouwer FC, Ferdinandusse S et al (2017) Clinical and laboratory diagnosis of peroxisomal disorders. Methods Mol Biol 1595:329\u2013342","journal-title":"Methods Mol Biol"},{"key":"523_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s10545-008-0856-3","volume":"31","author":"S Weller","year":"2008","unstructured":"Weller S, Rosewich H, G\u00e4rtner J (2008) Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients. J Inherit Metab Dis 31:270\u2013280","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-019-00523-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13353-019-00523-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-019-00523-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T23:06:20Z","timestamp":1602889580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13353-019-00523-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1007\/s13353-019-00523-w","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"assertion":[{"value":"26 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}